SYS-CON MEDIA Authors: Bob Gourley, Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill

News Feed Item

ImaCor Launches Educational Mobile App for Critical Care

ImaCor, Inc., the developer of the world’s first and only hemodynamic transesophageal echocardiography (hTEE) technology, today released the hTEE QuickStartTM mobile application. This app complements ImaCor’s comprehensive hTEE training program and provides clinicians easy access to how-to videos, patient case reviews, and 24/7 customer support.

ImaCor's hTEE QuickStart app is a handy tool that complements ImaCor's comprehensive training progra ...

ImaCor's hTEE QuickStart app is a handy tool that complements ImaCor's comprehensive training program, and is ideal for on the go or at the patient bedside. (Photo: Business Wire)

hTEE is a patient-centric technology, enabling physicians to directly visualize the heart to make better, faster treatment decisions for complex ICU patients. The hTEE ClariTEE® probe can be left indwelling for up to 72 hours so that clinicians can see the real-time effect on the heart of any dynamic adjustments in patient management. Cardiac, surgical critical care, and trauma thought leaders are using hTEE to optimize clinical and financial outcomes.

“hTEE technology provides critical information when ICU clinicians need it most,” commented Peter Pellerito, ImaCor’s President/CEO. “We developed the hTEE QuickStart app to make it even easier to use hTEE technology. Now, critical care teams can access clinical support and education anywhere on a mobile device, including right at the ICU patient bedside.”

The hTEE QuickStart app runs on iPhone®, iPad® and AndroidTM devices and is available for free download at the App Store and Google playTM. The app can also be accessed from any mobile browser at

About ImaCor

ImaCor, Inc. is a privately held company headquartered in Garden City, NY. The company designs, manufactures, and distributes advanced solutions for hemodynamic assessment in the critical care environment for the purpose of improving patient outcomes and optimizing utilization of healthcare resources.

ImaCor manufactures the ClariTEE® probe, the only miniaturized, indwelling TEE probe suitable for long-term clinical settings. hTEE™, Zura™, Zura EVO™, Adaptaflex™, and ClariTEE® are trademarks of ImaCor, Inc. For more information, please visit our website at

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.